Clinical Trial Update: Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of infliximab on insulin sensitivity and beta cell function in insulin-resistant obesity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Medical University of Graz | Conditions: Obesity, Insulin Resistance | Phase 4 | Status: COMPLETED